Novavax, Inc.

$NVAX has crossed above both its 50 and 200DMA so far today as they raised their annual revenue forecast on vaccine supply partnerships

Share this article:

About the Author:

Novavax, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup